HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

47.020

-1.180-2.45%

Volume:5.95M

Turnover:285.24M

Market Cap:312.07B

PE:34.18

High:49.000

Open:48.300

Low:46.900

Close:48.200

52wk High:94.869

52wk Low:46.900

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:3.41

T/O Rate:2.31%

Dividend:0.23

Dividend Rate:0.50%

EPS(LYR):1.376

ROE:12.46%

ROA:7.02%

PB:4.15

PE(LYR):34.18

PS:8.55

Loading ...

Overview Company News Filings

Movement Alert｜Hengrui Pharma Rises 4.01% in Regular Trading, Pharmaceutical Sector Rallies Amid Multiple Drug Approval Catalysts

AH Share Premium and Deviation Rankings for July 3rd

Movement Alert｜Hengrui Pharma Rises 3.2% in Regular Trading, Multiple New Drug Approvals and Priority Review Catalyze Gains

Hengrui Pharma Gets Nod to Trial Drug Combination for Hepatocellular Carcinoma

MT Newswires Live

Hengrui Pharma Reports Cumulative Share Buyback Totaling 13.47 Million A-Shares as of June 30

Hengrui Pharma Gains Regulatory Nod for Clinical Trials of Three Drug Candidates

HENGRUI PHARMA Keeps H-Share Capital Steady, Ups A-Share Treasury Stock via RMB 66.1 Million Buy-back in June

Bulletin Express

Hengrui Pharma Shares Surge Over 6% on New Drug Indication Approval and International Expansion Success

Movement Alert｜Hengrui Pharma Rises 3.72% in Regular Trading, Pharmaceutical Sector Rally and Multiple Drug Approvals Drive Gains

AH Share Premium and Deviation Rankings as of July 1st Close

AH Share Premium and Deviation Rankings as of June 30th Close

AH Share Premium and Deviation Data for June 29th

Movement Alert｜Hengrui Pharma Rises 3.02% in Regular Trading, Pharma Sector Rallies as Multiple Regulatory Milestones Boost Sentiment

AH Share Premium and Deviation Rankings for June 26

Hengrui Pharma Gets Nod to Trial HRS-4508 Tablets As Advanced Tumor Treatment; Shares Down 4%

MT Newswires Live

Hengrui Pharmaceuticals Unit Wins China Approval to Expand Indication of Cancer Drug

MT Newswires Live

Movement Alert｜Hengrui Pharmaceuticals Falls 3.53% in Regular Trading, Trading at 54.15 HKD

Hengrui Pharmaceuticals Unit Wins China Marketing Approval for Dry Eye Drug

MT Newswires Live

Hengrui Pharma Secures NMPA Approval for Adebrelimab as China’s First Domestic Peri-operative PD-L1 Therapy for Resectable NSCLC

Bulletin Express

Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/01276/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":47.02,"timestamp":1787538392564,"preClose":48.2,"halted":0,"volume":5949000,"delay":0,"changeRate":-0.02448132780082987,"floatShares":258000000,"shares":6637000000,"eps":1.3756647752210167,"marketStatus":"Trading","change":-1.18,"latestTime":"08-24 10:26:35","open":48.3,"high":49,"low":46.9,"amount":285241529,"amplitude":0.043568,"askPrice":47.04,"askSize":4200,"bidPrice":47.02,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":1.3566502900652075,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1787544000000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":48.2,"dividendRate":0.004963,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"volumeRatio":3.409099,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":47.15,"timestamp":1787538393000,"preClose":47.74,"halted":0,"volume":32616700,"delay":0,"premium":"-14.46"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.375665,"volumeRatio":3.409099,"shares":6637000000,"dividePrice":0.233164,"high":49,"amplitude":0.043568,"preClose":48.2,"low":46.9,"week52Low":46.9,"pbRate":"4.15","psRate":"8.55","week52High":94.869,"institutionHeld":0,"latestPrice":47.02,"committee":-0.555556,"eps":1.3756647752210167,"divideRate":0.004959,"volume":5949000,"delay":0,"ttmEps":1.3566502900652075,"open":48.3,"prevYearClose":71.002,"prevWeekClose":48.2,"prevMonthClose":57.1,"prevQuarterClose":57.85,"fiveDayClose":53.7,"twentyDayClose":57.05,"sixtyDayClose":58.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-08-21","current":33.84535,"percent":0.064935,"low":37.44534,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"high":65.582363,"avg":51.795451,"sd":7.046662,"marketCap":366558497066.13},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13}],"updateTime":1787518826644},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166448587","title":"Movement Alert｜Hengrui Pharma Rises 4.01% in Regular Trading, Pharmaceutical Sector Rallies Amid Multiple Drug Approval Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1166448587","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166448587?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:09","pubTimestamp":1783303748,"startTime":"0","endTime":"0","summary":"On July 6, Hengrui Pharma rose 4.01% in regular trading, reaching HKD 62.45 per share, with turnover of approximately HKD 125 million. The pharmaceutical sector rallied broadly, with Haixi Pharma up...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151101203","title":"AH Share Premium and Deviation Rankings for July 3rd","url":"https://stock-news.laohu8.com/highlight/detail?id=1151101203","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151101203?lang=en_us&edition=fundamental","pubTime":"2026-07-03 16:26","pubTimestamp":1783067166,"startTime":"0","endTime":"0","summary":"As of the market close on July 3rd, the top three stocks with the highest AH share premium rates were NE ELECTRIC (HKG: 00042), ZHEJIANG SHIBAO (HKG: 01057), and ANDRE JUICE (HKG: 02218), with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU1861219969.SGD","BK1161","BK1522","LU0516423091.SGD","BK1523","LU2152927971.USD","LU1282651121.HKD","LU1064131342.USD","LU1051768304.USD","LU1044875133.USD","LU0456827905.SGD","HK0000320223.HKD","LU0593848301.USD","LU1328277881.USD","LU2242644610.SGD","LU0630378429.USD","LU0163747925.USD","LU2778985437.USD","LU0469268626.HKD","LU1244550577.SGD","LU0051755006.USD","LU0164939612.USD","LU1224709979.USD","BK1515","IE0008369823.USD","LU0329678170.USD","LU1051769294.HKD","LU1868837565.USD","LU0143863198.USD","LU2097828474.EUR","BK1171","BK1154","LU2506951792.HKD","BK1514","LU0651946864.USD","BK1501","LU2153591404.USD","LU0572944931.SGD","LU0117844026.USD","BK1214","LU0289739343.SGD","LU0287142896.SGD","LU1688375341.USD","LU0359201612.USD","LU0370786039.SGD","LU0072462343.USD","LU0588546209.SGD","IE00BVYPNQ40.USD","LU0326950275.SGD","LU1813983027.USD","SG9999001226.SGD","BK1506","LU0511384066.AUD","LU1769817096.USD","LU1152091754.HKD","BK1546","LU0117841782.USD","02218","BK1116","LU0449509016.USD","IE00BD6J9T35.USD","IE0031814852.USD","BK1521","LU0228659784.USD","LU0348788117.USD","01812","03143","00956","LU0880133367.SGD","BK1141","BK1560","HK0000352291.HKD","LU2045819591.USD","LU0823426480.USD","IE00B031J352.USD","LU0531971595.HKD","LU0650527681.SGD","LU0229945570.USD","00300","IE00BZ08YR35.GBP","LU0516422366.SGD","LU0384037296.USD","02318","LU1226287529.USD","BK1576","BK1202","LU0831093199.SGD","BK1149","LU2294711713.HKD","399300","HPAD.SI","03200","IE0003895053.USD","LU0348767384.USD","LU0165289439.USD","SG9999011746.SGD","LU0543330483.HKD","LU1861214812.USD","BK1193","BK1583","03145","LU0441854154.USD","IE00BF5LJ272.USD","LU0307460666.USD","LU1282648689.USD","IE00BVYPNP33.GBP","LU1044876610.USD","LU0320764755.SGD","LU0819121731.USD","LU0128522157.USD","LU1880383366.USD","LU1366334578.USD","LU0048580855.USD","LU0173614495.USD","LU0823038988.USD","02359","LU2125910500.SGD","LU2449936058.SGD","HYDD.SI","LU1960683339.HKD","LU1868838027.USD","LU0630378692.HKD","LU3063872942.SGD","IE00B29SXG58.USD","LU0543330566.HKD","LU1023057109.AUD","LU0084288322.USD","LU0348784397.USD","LU0588545490.SGD","LU0149721374.USD","01033","LU0605514214.HKD","LU0072913022.USD","LU0348805143.USD","BK1183","BK1198","LU1146622755.USD","06869","LU1008478684.HKD","LU1366334651.USD","LU0348827113.USD","LU1282649067.USD","LU2357125470.USD","BK1507","LU0417516571.SGD","LU0328353924.USD","BYDDY","LU1242518931.SGD","LU0502904849.HKD","LU0266512473.USD","LU0516422440.USD","BK1240","BK1166","LU0882747503.HKD","IE0034224299.USD","BK1610","LU1988902786.USD","LU0329678337.USD","LU0588545904.SGD","LU0067412154.USD","00916","IE00BZ08YT58.USD","03908","LU0082770016.USD","LU0049112450.USD","SG9999002463.SGD","LU0890818403.SGD","LU0327786744.USD","LU2348774022.SGD","LU0823414551.USD","LU2039709279.SGD","BK1550","IE00B543WZ88.USD","IE00BYV24P56.USD","LU1504937902.USD","BK1184","IE00BGHQDM52.EUR","LU0106959298.USD","IE00BMCWC346.EUR","00042","LU1794554557.SGD","02338","LU0417516738.SGD","LU1224444064.USD","LU0348735423.USD","LU0505663152.USD","IE00B3M56506.USD","LU2097828557.USD","SG9999006597.SGD","BK1125","HK0000252152.HKD","LU1115378108.SGD","LU0320764599.SGD","LU0561508036.HKD","HK0000320264.USD","LU1282649810.SGD","LU1675838814.USD","06166","06185","LU0918141705.HKD","BK1191","LU0828237940.HKD","LU1719994722.HKD","LU1152091168.USD","SG9999002562.SGD","LU1242518857.USD","LU1282651048.USD","LU1105468828.SGD","BK1594","IE00B5MMRT66.SGD","LU2177674079.SGD","02691","LU1655091459.SGD","LU0210526637.USD","LU0348814723.USD","LU0431992006.USD","BK1110","LU1244550494.USD","LU0293314216.USD","LU1868837722.USD","02899","LU0823426308.USD","LU0878004406.USD","LU2264538146.SGD","LU0823039010.USD","LU2348773727.SGD","BK1237","LU0456854461.SGD","LU1808992512.USD","LU2008162690.USD","HK0000352382.USD","LU1720050803.USD","BK1558","LU0197773673.USD","LU0821914370.USD","LU0488056044.USD","LU2249611893.SGD","01276","LU0856984785.SGD","LU0348825331.USD","LU2476274720.SGD","LU0196878994.USD","LU0043850808.USD","LU2153592121.USD","LU1642822792.SGD","HK0000306701.USD","LU2360107325.USD","03986","06031","LU0211977185.USD","LU0862451837.USD","LU0315178854.USD","LU1044874839.SGD","BK1582","BK1539","BK1516","BK1592","IE00B0169L03.USD","LU0828237510.HKD","LU0865486749.SGD","LU0607220059.USD","03750","LU0675040207.SGD","HK0000306685.HKD","LU0228367735.SGD","BK1147","LU0254981946.USD","LU0359202008.SGD","LU0737861699.HKD","00895","LU1981816686.USD","LU1831875114.USD","LU0634319403.HKD","01057","BK1574","LU0082770016.SGD","LU1303224171.USD","LU0516423174.USD","LU2293587155.HKD","LU0320764243.SGD","EWH","LU0588545730.USD","LU0540923850.HKD","BK1537","LU1769817179.HKD","LU0878005551.USD","LU0708995153.HKD","SG9999015952.SGD","LU0345780521.USD","LU0594300419.USD","SG9999001903.USD","LU0828238088.HKD","BK1505","BK1509","LU1807302812.USD","LU0797268264.HKD","LU0269904917.USD","LU0244354667.USD","LU0463099449.HKD","LU0868486357.SGD","LU2097828805.USD","01349","LU0516422952.EUR","LU1188198961.HKD","LU0672654166.SGD","BK1119","LU1961090484.USD","LU0918141887.USD","01138","LU0061477393.USD","LU0348766576.USD","002594","LU0143863784.USD","LU0823414478.USD","LU1515016050.SGD","SG9999014674.SGD","BK1223","LU0231483743.USD","HK0000286598.CNH","LU0417516902.SGD","159982","LU0737861772.HKD","LU1046422090.SGD","LU0314109678.HKD","LU0164865239.USD","LU1048596156.SGD","82318","LU0289960550.SGD","LU0611395673.USD","LU0197773160.USD","LU2424517915.HKD","BK1231","LU0898667661.SGD","LU0509642566.USD","LU0620787316.HKD","LU0011963245.USD","LU0819123356.HKD","03296","LU0128522744.USD","LU0359201885.HKD","BK1163","01211","LU0348816934.USD","SG9999000459.SGD","LU0348783233.USD","PAImain","LU1048588211.SGD","BK1540","LU2543165471.USD","HK0000500386.USD","SG9999006514.SGD","LU0289961442.SGD","LU0235996351.USD","BK1544","LU1235295612.USD","IE00B031HY20.USD","BK1551","LU0791590937.USD","LU0531970944.HKD","06693","LU0106252389.USD","LU0708995583.HKD","LU0501845795.SGD","SG9999004220.SGD","LU0214875030.USD","BK1562","601318","LU1993786604.SGD","LU0640798160.USD","LU0266512127.USD","IE0008368742.USD","HK0001040168.HKD","LU0589944569.HKD","LU0029875118.USD","LU0456846285.SGD","LU0762540952.USD","LU0054450605.USD","LU0449515922.USD","SG9999015978.USD","LU0651947912.USD","LU0791591158.USD","LU0455707207.USD","LU0164872284.USD","BK1503","LU0052750758.USD","SG9999002828.SGD","BK1144","LU0049853897.USD","LU0979878070.USD","LU0594300179.USD","LU2476274308.USD","BK1552","LU1770034418.SGD","LU0784639295.USD","03678","HK0000252160.HKD","PNGAY","LU0648948544.HKD","02465","02715","LU2294711473.HKD","BK1530","LU0096374516.USD","BK1535","LU0315179316.USD","03968","LU0348783662.USD","LU0039217434.USD","LU0140636845.USD","LU0181495838.USD","LU0762542818.HKD","HK0001040143.USD","LU0823040885.USD","LU0164880469.USD","IE0032431581.USD","LU2399975544.HKD","LU0886674414.USD","HK0000151867.HKD","LU0175139822.USD","LU1880383440.USD","LU0149534421.HKD","LU0862451753.SGD","LU0345780281.USD","IE00BZ08YS42.EUR","LU2097828631.EUR","LU2226246903.HKD","LU1251922891.USD","LU0259732245.USD","LU1481107354.HKD","LU0831103253.SGD","81211","LU1244550221.USD","SG9999015986.USD","BK1140","BK1564","LU1820825898.SGD","00991","LU0762541174.USD","LU1211504680.USD","LU0871576103.HKD","LU1282649141.HKD","LU2097828714.EUR","LU0210527791.USD","SG9999015945.SGD","LU0029874905.USD","02701"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164029658","title":"Movement Alert｜Hengrui Pharma Rises 3.2% in Regular Trading, Multiple New Drug Approvals and Priority Review Catalyze Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1164029658","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164029658?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:47","pubTimestamp":1783043225,"startTime":"0","endTime":"0","summary":"On July 3, Hengrui Pharma rose 3.2% in regular trading, trading at HKD 60.4/share, with turnover of HKD 51.29 million. The stock was buoyed by a wave of positive catalysts and broad pharmaceutical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648632449","title":"Hengrui Pharma Gets Nod to Trial Drug Combination for Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2648632449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648632449?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:43","pubTimestamp":1783043039,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals , through its subsidiaries, received approval from China's National Medical Products Administration for the clinical trials of a drug combination for the treatment of hepatocellular carcinoma, according to a Shanghai bourse filing on Friday.The pharmaceutical company was given the green light to trial SHR-8068 injection in combination with adebelimab injection, and apatinib mesylate tablets.Adebelimab injection was already approved as a lung cancer treatment, while apatinib mesylate tablets was approved as a treatment for various cancers, including gastric, hepatocellular and breast cancer.The company's Hong Kong shares rose 2% and Shanghai shares increased 1% during the morning trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2097828557.USD","LU2580892862.HKD","LU1023057109.AUD","600276","LU2495084118.USD","LU2097828805.USD","LU1146622755.USD","LU1064130708.USD","LU1781817850.SGD","LU2097828714.EUR","LU1064131003.USD","BK0012","LU0359201612.USD","LU2289578879.USD","BK1191","LU2488822045.USD","BK0188","BK0028","BK0060","BK0183","LU1969619763.USD","LU2097828631.EUR","LU2543165471.USD","LU0359201885.HKD","LU2580892789.USD","LU2097828474.EUR","LU1655091616.SGD","LU1255011170.USD","LU1997245177.USD","LU0359202008.SGD","LU1997244956.HKD","BK0239","LU1997245094.SGD","LU2148510915.USD","LU1328615791.USD","BK0196","LU0405327494.USD","LU0405327148.USD","01276","LU1820825898.SGD","LU2328871848.SGD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180673816","title":"Hengrui Pharma Reports Cumulative Share Buyback Totaling 13.47 Million A-Shares as of June 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1180673816","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180673816?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:41","pubTimestamp":1782992511,"startTime":"0","endTime":"0","summary":"Hengrui Pharma has provided an update on its progress regarding the repurchase of its A-shares.During the month of June 2026, the company repurchased 1.414 million shares through the Shanghai Stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU2580892789.USD","BK1191","LU2580892862.HKD","LU1255011170.USD","LU2289578879.USD","LU1328615791.USD","BK0060","LU0405327148.USD","LU1997244956.HKD","BK0012","LU2495084118.USD","LU1023057109.AUD","LU2097828474.EUR","LU2097828805.USD","LU1997245177.USD","LU1146622755.USD","LU2328871848.SGD","LU1969619763.USD","LU0359201612.USD","600276","LU1781817850.SGD","LU2543165471.USD","LU2097828714.EUR","BK0183","LU0359201885.HKD","LU2148510915.USD","BK0196","LU0359202008.SGD","BK0188","LU1064131003.USD","399300","LU2097828557.USD","LU2097828631.EUR","LU1064130708.USD","LU1580142542.USD","BK0028","159982","LU1997245094.SGD","BK0239","LU0405327494.USD","LU1655091616.SGD","LU1820825898.SGD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130917404","title":"Hengrui Pharma Gains Regulatory Nod for Clinical Trials of Three Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1130917404","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130917404?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:16","pubTimestamp":1782983789,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHSE: 600276) has announced that it, along with its subsidiaries Suzhou Shengdiya Biopharmaceutical Co., Ltd. and Shanghai Shengdi Pharmaceutical Co., Ltd.,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","LU2580892789.USD","LU1997245094.SGD","BK0188","LU1820825898.SGD","BK0060","LU1781817850.SGD","BK0183","LU2328871848.SGD","LU1328615791.USD","LU2097828631.EUR","LU1580142542.USD","LU1997244956.HKD","BK0196","LU0405327494.USD","BK1191","LU2580892862.HKD","LU0359201612.USD","LU1146622755.USD","LU1064130708.USD","LU2097828714.EUR","LU2148510915.USD","BK0239","600276","BK0028","LU2097828805.USD","LU2488822045.USD","LU1064131003.USD","LU2495084118.USD","LU1023057109.AUD","LU1655091616.SGD","BK0012","LU1969619763.USD","LU0359202008.SGD","LU0405327148.USD","LU2543165471.USD","LU2097828557.USD","LU2097828474.EUR","LU1997245177.USD","LU2289578879.USD","LU1255011170.USD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169688131","title":"HENGRUI PHARMA Keeps H-Share Capital Steady, Ups A-Share Treasury Stock via RMB 66.1 Million Buy-back in June","url":"https://stock-news.laohu8.com/highlight/detail?id=1169688131","media":"Bulletin Express","labels":["shareholding","SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169688131?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:44","pubTimestamp":1782981845,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (HENGRUI PHARMA) filed its Monthly Return for June 2026, highlighting stable Hong Kong–listed H-share capital alongside increased A-share treasury holdings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162514605","title":"Hengrui Pharma Shares Surge Over 6% on New Drug Indication Approval and International Expansion Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1162514605","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162514605?lang=en_us&edition=fundamental","pubTime":"2026-07-02 10:32","pubTimestamp":1782959548,"startTime":"0","endTime":"0","summary":"Shares of Hengrui Pharma (ASX: 01276) surged more than 6% during the trading session. At the time of writing, the stock was up 3.54% to HKD 59.9, with a turnover of HKD 136 million.The recent price...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","LU2097828557.USD","LU2580892789.USD","LU0405327148.USD","LU1997244956.HKD","LU2328871848.SGD","BK4588","LU2148510915.USD","LU1255011170.USD","LU2580892862.HKD","LU2097828474.EUR","LU1997245094.SGD","LU1781817850.SGD","159992","VXUS","LU1064131003.USD","LU1328615791.USD","BK0028","LU1969619763.USD","LU2097828714.EUR","LU2495084118.USD","LU1023057109.AUD","LU2097828631.EUR","LU2097828805.USD","06978","BK1161","LU1064130708.USD","BK0012","BK4585","BK0183","LU1580142542.USD","LU2488822045.USD","LU1146622755.USD","LU0359201612.USD","BK0060","01276","LU0359201885.HKD","LU1997245177.USD","BK0239","BK0196","LU1655091616.SGD","LU2289578879.USD","LU0405327494.USD","BK0188","BK1191","BK1574","LU1820825898.SGD","LU2543165471.USD","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189981461","title":"Movement Alert｜Hengrui Pharma Rises 3.72% in Regular Trading, Pharmaceutical Sector Rally and Multiple Drug Approvals Drive Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1189981461","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189981461?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:36","pubTimestamp":1782956176,"startTime":"0","endTime":"0","summary":"On July 2, Hengrui Pharma rose 3.72% in regular trading, trading at HK$61.5/share, with turnover of HK$49.77 million. The stock gained alongside a broad pharmaceutical sector rally, with CSPC Pharma...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130982688","title":"AH Share Premium and Deviation Rankings as of July 1st Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1130982688","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130982688?lang=en_us&edition=fundamental","pubTime":"2026-07-01 16:24","pubTimestamp":1782894266,"startTime":"0","endTime":"0","summary":"As of the market close on July 1st, the top three stocks with the highest AH share premium rates were NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and ANDRE JUICE (02218), with premiums of 864.29%,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU0214875030.USD","LU2264538146.SGD","SG9999011746.SGD","LU0072913022.USD","LU0543330566.HKD","BK1191","BK1503","LU0463099449.HKD","LU1282649810.SGD","IE00B3M56506.USD","02476","LU0315179316.USD","IE00BVYPNP33.GBP","LU1152091168.USD","00956","BK1583","LU0029875118.USD","LU2045819591.USD","LU1105468828.SGD","IE00B5MMRT66.SGD","LU2778985437.USD","BK1594","LU1282649141.HKD","02338","LU1769817179.HKD","EWH","LU0516423174.USD","LU0106959298.USD","LU0096374516.USD","LU0516422366.SGD","02899","BK1521","IE00B031HY20.USD","LU0797268264.HKD","LU2039709279.SGD","159982","02691","LU2399975544.HKD","LU0737861772.HKD","LU1226287529.USD","BK1537","LU0320764599.SGD","LU1880383366.USD","LU0348816934.USD","BK1576","LU0266512473.USD","BK1178","LU1960683339.HKD","LU0149721374.USD","LU0791591158.USD","LU0918141705.HKD","LU2008162690.USD","LU0348767384.USD","BK1610","IE00B543WZ88.USD","LU1366334578.USD","02208","IE00B0169L03.USD","HK0000306685.HKD","LU2226246903.HKD","LU0244354667.USD","BK1513","LU1244550221.USD","LU0140636845.USD","LU0054450605.USD","01033","LU1961090484.USD","BK1140","LU0061477393.USD","IE00BVYPNQ40.USD","LU0164939612.USD","LU1244550577.SGD","LU1064131342.USD","LU0516422440.USD","IE00BYV24P56.USD","LU0456846285.SGD","BK1235","02218","IE0031814852.USD","LU0117841782.USD","LU0328353924.USD","LU1211504680.USD","LU2242644610.SGD","LU2097828557.USD","LU0516423091.SGD","LU0880133367.SGD","LU0231483743.USD","LU0165289439.USD","BK1173","03268","LU0326950275.SGD","LU1224709979.USD","LU0634319403.HKD","HK0000320264.USD","BK1544","IE0008369823.USD","BK1110","00895","02465","LU1188198961.HKD","LU1688375341.USD","LU0488056044.USD","HK0000352382.USD","BK1105","00991","01276","BK1562","LU1048596156.SGD","LU0039217434.USD","BK1163","LU0531971595.HKD","02359","BK1116","01108","BK1560","LU0163747925.USD","LU2097828714.EUR","IE00B29SXG58.USD","LU2097828805.USD","LU1504937902.USD","LU1807302812.USD","LU0348805143.USD","BK1209","LU0327786744.USD","LU1328277881.USD","BK1231","LU0359202008.SGD","LU1115378108.SGD","LU0708995583.HKD","LU0502904849.HKD","SG9999006597.SGD","LU0417516902.SGD","LU1023057109.AUD","IE00B031J352.USD","LU0228659784.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU0672654166.SGD","LU1769817096.USD","03296","LU0348766576.USD","LU0821914370.USD","00042","03750","LU0871576103.HKD","HK0000500386.USD","LU0886674414.USD","BK1183","BK1198","LU0052750758.USD","LU0359201885.HKD","LU0620787316.HKD","LU2177674079.SGD","IE00BGHQDM52.EUR","LU0211977185.USD","399300","LU0516422952.EUR","LU0868486357.SGD","BK1144","IE00BF5LJ272.USD","BK1505","LU0979878070.USD","BK1515","LU1251922891.USD","LU1242518931.SGD","LU0173614495.USD","IE0008368742.USD","LU0314109678.HKD","LU0329678337.USD","BK1237","LU0572944931.SGD","LU0455707207.USD","LU0417516738.SGD","LU0456827905.SGD","IE0034224299.USD","01057","HK0000306701.USD","LU1988902786.USD","03678","LU0106252389.USD","LU0561508036.HKD","BK1522","LU0082770016.USD","LU0791590937.USD","SG9999004220.SGD","01081","LU0051755006.USD","LU1282648689.USD","LU0890818403.SGD","IE00BZ08YR35.GBP","LU0823426308.USD","LU0181495838.USD","LU0589944569.HKD","LU1813983027.USD","BK1170","LU0862451753.SGD","HK0000352291.HKD","LU1244550494.USD","LU0607220059.USD","HK0000252160.HKD","LU1719994722.HKD","BK1554","LU0348788117.USD","03369","LU0329678170.USD","LU0828237510.HKD","LU0543330483.HKD","01349","LU1720050803.USD","LU0307460666.USD","LU0048580855.USD","LU0828237940.HKD","LU0449515922.USD","LU1794554557.SGD","LU0043850808.USD","LU1282649067.USD","BK1147","BK1193","LU1008478684.HKD","BK1592","LU0359201612.USD","LU0348735423.USD","03200","BK1141","BK1530","LU1303224171.USD","LU0501845795.SGD","BK1552","LU2476274720.SGD","LU1880383440.USD","LU0370786039.SGD","LU1770034418.SGD","LU0456854461.SGD","LU1831875114.USD","LU1481107354.HKD","00916","LU0164880469.USD","LU0254981946.USD","SG9999002828.SGD","LU0449509016.USD","LU2294711473.HKD","IE00BMCWC346.EUR","IE00BZ08YS42.EUR","LU0049853897.USD","01088","LU0593848301.USD","LU0348814723.USD","03866","BK1205","BK1558","HK0000252152.HKD","00588","LU0228367735.SGD","LU0531970944.HKD","LU0149534421.HKD","LU0345780521.USD","LU0164865239.USD","01989","LU2125910500.SGD","LU1152091754.HKD","BK1538","BK1546","LU0345780281.USD","00719","LU0588546209.SGD","LU0431992006.USD","LU0648948544.HKD","BK1240","LU1046422090.SGD","LU0348825331.USD","LU0640798160.USD","LU0918141887.USD","BK1171","LU2543165471.USD","LU0128522157.USD","BK1154","BK1202","IE0032431581.USD","LU0823426480.USD","BK1526","BK1166","BK1507","LU1808992512.USD","LU0287142896.SGD","SG9999014674.SGD","LU0082770016.SGD","LU0737861699.HKD","LU2097828474.EUR","BK1149","LU0540923850.HKD","LU0266512127.USD","BK1535","03143","HK0000320223.HKD","LU0348827113.USD","03986","02715","BK1125","BK1214","LU1366334651.USD","LU3063872942.SGD","LU0469268626.HKD","LU2097828631.EUR","LU0320764755.SGD","LU1993786604.SGD","00300","BK1564","SG9999002463.SGD","LU0384037296.USD","LU2476274308.USD","LU0229945570.USD","03968","LU0823040885.USD","LU1675838814.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151864929","title":"AH Share Premium and Deviation Rankings as of June 30th Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1151864929","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151864929?lang=en_us&edition=fundamental","pubTime":"2026-06-30 16:24","pubTimestamp":1782807883,"startTime":"0","endTime":"0","summary":"As of the market close on June 30th, the top three stocks with the highest AH share premium rates were NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and ANDRE JUICE (02218), with premiums of 864.29%,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0797268264.HKD","LU0918141887.USD","LU1675838814.USD","LU0315179316.USD","HK0000500386.USD","LU0516423091.SGD","LU2476274308.USD","LU1719994722.HKD","LU1023057109.AUD","LU0320764599.SGD","LU0348766576.USD","HK0000252152.HKD","LU0823040885.USD","LU0488056044.USD","BK1163","LU0329678337.USD","LU0449515922.USD","399300","IE00BMCWC346.EUR","LU2543165471.USD","BK1205","IE00BVYPNP33.GBP","LU1770034418.SGD","LU0516422440.USD","LU1008478684.HKD","LU0049853897.USD","00300","IE00B29SXG58.USD","BK1552","LU0607220059.USD","LU0737861772.HKD","LU0164939612.USD","LU0214875030.USD","LU0531971595.HKD","LU0320764755.SGD","BK1535","LU0149534421.HKD","LU0456846285.SGD","LU1328277881.USD","LU2399975544.HKD","LU2097828474.EUR","BK1141","IE00BZ08YS42.EUR","LU2097828805.USD","01108","BK1562","LU0359202008.SGD","LU0165289439.USD","02865","IE00BPRC5H50.USD","IE00BZ08YR35.GBP","HK0000320223.HKD","LU0348788117.USD","01033","BK1178","LU0672654166.SGD","06031","LU0634319403.HKD","LU1282648689.USD","IE00B543WZ88.USD","LU0266512473.USD","BK1151","LU2039709279.SGD","LU1831875114.USD","LU1813983027.USD","HK0000352291.HKD","LU2045819591.USD","BK1144","BK1173","LU0082770016.USD","LU0106252389.USD","BK1231","LU0348735423.USD","LU1244550577.SGD","LU0128522157.USD","00042","IE0008368742.USD","BK1564","LU1366334651.USD","LU1152091168.USD","LU1769817096.USD","LU0572944931.SGD","LU0648948544.HKD","LU0329678170.USD","LU0456854461.SGD","BK1594","BK1240","LU0140636845.USD","BK1583","LU0737861699.HKD","LU0181495838.USD","LU0823426308.USD","00390","LU0244354667.USD","BK1538","LU1064131342.USD","BK1507","03678","LU0096374516.USD","LU1880383440.USD","02465","LU0640798160.USD","LU2476274720.SGD","BK1148","LU1282649067.USD","IE0032431581.USD","LU0048580855.USD","LU0862451753.SGD","LU0516422366.SGD","01276","LU0117841782.USD","HK0000352382.USD","LU0540923850.HKD","IE00BYV24P56.USD","BK1546","01138","BK1198","LU0082770016.SGD","LU2264538146.SGD","LU0828237510.HKD","LU0543330566.HKD","LU0531970944.HKD","LU0821914370.USD","LU0588546209.SGD","BK1214","BK1544","BK1237","LU0054450605.USD","LU0516423174.USD","LU0345780521.USD","IE00B031HY20.USD","IE00BVYPNQ40.USD","LU0266512127.USD","01057","LU1105468828.SGD","IE00B5MMRT66.SGD","BK1191","LU1769817179.HKD","BK1125","LU0039217434.USD","LU0326950275.SGD","BK1183","BK1537","LU1504937902.USD","LU0886674414.USD","LU0348805143.USD","LU1961090484.USD","LU0051755006.USD","LU0979878070.USD","IE00BZ08YT58.USD","LU1481107354.HKD","LU0348814723.USD","SG9999011746.SGD","LU1282649141.HKD","03986","LU0149721374.USD","LU1152091754.HKD","LU0067412154.USD","IE00BF5LJ272.USD","03968","IE0031814852.USD","LU0228367735.SGD","02338","LU0307460666.USD","BK1116","LU1046422090.SGD","LU2226246903.HKD","LU2294711473.HKD","LU1807302812.USD","06936","LU0516422952.EUR","BK1610","IE0008369823.USD","BK1166","02218","LU2097828714.EUR","BK1513","LU0918141705.HKD","LU2778985437.USD","02701","159982","LU0164880469.USD","LU1988902786.USD","IE0034224299.USD","LU0348816934.USD","LU1224709979.USD","03296","LU0456827905.SGD","HK0000306685.HKD","00719","BK1140","03200","02691","LU0254981946.USD","LU0231483743.USD","LU2242644610.SGD","LU1251922891.USD","LU0871576103.HKD","BK1171","LU0211977185.USD","LU1244550221.USD","03369","LU0348827113.USD","BK1522","LU2008162690.USD","SG9999002463.SGD","LU0620787316.HKD","LU1226287529.USD","HK0000252160.HKD","LU0052750758.USD","LU1115378108.SGD","LU0328353924.USD","LU2097828631.EUR","LU0868486357.SGD","LU0228659784.USD","00916","LU0463099449.HKD","BK1558","LU1366334578.USD","BK1554","LU0543330483.HKD","HK0000306701.USD","LU1720050803.USD","LU0043850808.USD","02359","LU0173614495.USD","BK1105","LU0501845795.SGD","LU0029875118.USD","IE00BGHQDM52.EUR","LU1303224171.USD","SG9999002828.SGD","IE00B031J352.USD","03750","LU1048596156.SGD","LU0589944569.HKD","LU0561508036.HKD","BK1193","LU0455707207.USD","LU0345780281.USD","LU0791590937.USD","SG9999004220.SGD","LU1794554557.SGD","LU1242518931.SGD","02899","EWH","BK1576","LU0708995583.HKD","LU0359201885.HKD","00956","LU0287142896.SGD","LU1960683339.HKD","BK1503","LU0469268626.HKD","01088","LU0072913022.USD","LU0327786744.USD","BK1560","LU0314109678.HKD","HK0000320264.USD","LU1244550494.USD","SG9999014674.SGD","LU1993786604.SGD","LU1242518857.USD","00588","LU2097828557.USD","LU0229945570.USD","BK1154","BK1202","LU0593848301.USD","LU1880383366.USD","LU0384037296.USD","LU2125910500.SGD","IE00B0169L03.USD","LU1688375341.USD","LU0348825331.USD","LU0348767384.USD","IE00B3M56506.USD","LU1211504680.USD","02208","BK1515","SG9999006597.SGD","00895","03143","LU0431992006.USD","LU1808992512.USD","BK1110","LU1282649810.SGD","BK1592","LU0449509016.USD","LU0880133367.SGD","BK1147","LU0791591158.USD","09989","BK1565","BK1505","LU0417516738.SGD","BK1530","LU0502904849.HKD","LU0828237940.HKD","LU0370786039.SGD","LU0417516902.SGD","LU0823426480.USD","BK1526","LU2177674079.SGD","00991","LU0163747925.USD","LU2213484517.USD","LU0164865239.USD","01349","LU0890818403.SGD","LU0061477393.USD","LU0106959298.USD","LU0359201612.USD","LU1188198961.HKD","01081","BK1521","LU3063872942.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156215187","title":"AH Share Premium and Deviation Data for June 29th","url":"https://stock-news.laohu8.com/highlight/detail?id=1156215187","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156215187?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:24","pubTimestamp":1782721495,"startTime":"0","endTime":"0","summary":"Data as of the market close on June 29th shows NE ELECTRIC (HKG: 00042), ZHEJIANG SHIBAO (HKG: 01057), and SINOPEC SSC (HKG: 01033) had the highest AH share premium rates at 864.29%, 372.60%, and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1505","LU0320764599.SGD","LU0828237940.HKD","LU0287142896.SGD","LU0370786039.SGD","01108","LU0228659784.USD","LU0449509016.USD","LU1224444064.USD","LU0979878070.USD","02318","LU0384037296.USD","LU2097828474.EUR","LU1105468828.SGD","LU0067412154.USD","LU0469268626.HKD","BK1546","LU0868486357.SGD","BK1180","LU1115378108.SGD","BK1144","BK1583","LU0791590937.USD","LU1152091168.USD","IE00BF5LJ272.USD","LU0417516902.SGD","LU1242518857.USD","LU0049112450.USD","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","LU1235295612.USD","01057","LU2476274308.USD","LU1769817179.HKD","LU2264538146.SGD","BK1535","LU0862451837.USD","IE0034224299.USD","LU0819121731.USD","BK1193","IE00BGHQDM52.EUR","BK1231","EWH","LU1008478684.HKD","BK1523","LU0675040207.SGD","IE0008369823.USD","LU0266512127.USD","LU1044874839.SGD","IE00BZ08YS42.EUR","SG9999002562.SGD","LU0011963245.USD","LU0456846285.SGD","HK0001040168.HKD","82318","LU2294711473.HKD","LU2476274720.SGD","LU0797268264.HKD","LU0831103253.SGD","LU0039217434.USD","BK1544","IE00B543WZ88.USD","LU1504937902.USD","LU0329678170.USD","LU3063872942.SGD","LU0540923850.HKD","BK1513","LU0819123356.HKD","LU0791591158.USD","LU1794554557.SGD","00168","LU0594300179.USD","LU0244354667.USD","LU0163747925.USD","LU2348774022.SGD","LU0164880469.USD","SG9999006597.SGD","IE0031814852.USD","IE00BGV7N243.SGD","LU0672654166.SGD","02465","LU2153592121.USD","LU0052750758.USD","LU0516422366.SGD","LU0572944931.SGD","LU1282649067.USD","LU0359201612.USD","LU0918141887.USD","BK1191","LU1688375341.USD","LU0650527681.SGD","03200","03145","LU0214875030.USD","LU2039709279.SGD","BK1537","03678","HK0000306701.USD","LU1880383366.USD","HK0000286598.CNH","LU0164939612.USD","LU0359202008.SGD","LU0882747503.HKD","IE00B29SXG58.USD","LU0348735423.USD","LU0210526637.USD","HK0000320264.USD","LU1807302812.USD","LU0348766576.USD","02338","HK0000252160.HKD","LU2177674079.SGD","LU0345780521.USD","LU0054450605.USD","LU2226246903.HKD","LU0589944569.HKD","BK1149","LU0229945570.USD","LU0865486749.SGD","00187","BK1237","LU0630378429.USD","01033","SG9999004220.SGD","LU2097828805.USD","LU1770034418.SGD","SG9999011746.SGD","SG9999000459.SGD","LU2778985437.USD","LU0228367735.SGD","LU0314109678.HKD","LU0588546209.SGD","LU0117844026.USD","00300","BK1558","LU0348825331.USD","LU1044875133.USD","LU0823426480.USD","LU0878005551.USD","03661","LU2097828557.USD","01349","LU2348773727.SGD","LU0082770016.USD","LU0762541174.USD","01081","IE00B3M56506.USD","LU0543330483.HKD","LU0082770016.SGD","BK1235","LU2424517915.HKD","BK1507","LU0648948544.HKD","LU0455707207.USD","LU0072462343.USD","LU0307460666.USD","LU0516423174.USD","BK1202","LU0449515922.USD","LU0359201885.HKD","LU1993786604.SGD","LU0235996351.USD","LU0084288322.USD","BK1521","LU1282651048.USD","LU0488056044.USD","BK1141","03866","LU0630378692.HKD","LU0128522157.USD","LU0561508036.HKD","LU0348816934.USD","LU1051769294.HKD","SG9999014674.SGD","02359","IE00BZ08YT58.USD","LU0348784397.USD","03143","BK1116","LU1282648689.USD","PAImain","BK1510","BK1576","LU0898667661.SGD","BK1604","LU1831875114.USD","LU0531970944.HKD","LU0737861699.HKD","LU1960683339.HKD","399300","LU1244550221.USD","02208","03968","LU0417516571.SGD","LU0106959298.USD","IE00BZ08YR35.GBP","BK1154","LU2008162690.USD","03750","06066","PNGAY","LU1642822792.SGD","BK1610","LU0762542818.HKD","IE00B031HY20.USD","BK1522","LU0588545904.SGD","LU1046422090.SGD","LU0640798160.USD","LU0594300419.USD","BK1163","LU0823040885.USD","LU0821914370.USD","LU1051768304.USD","BK1198","LU0211977185.USD","LU0029875118.USD","LU0737861772.HKD","LU0210527791.USD","IE00BMCWC346.EUR","LU1675838814.USD","LU0417516738.SGD","LU0516422440.USD","BK1592","BK1562","HK0000306685.HKD","LU0348827113.USD","LU0651947912.USD","01276","LU0165289439.USD","HK0001040143.USD","BK1183","LU0880133367.SGD","LU1244550577.SGD","HPAD.SI","03986","LU0320764755.SGD","LU0441854154.USD","BK1564","LU2045819591.USD","LU1481107354.HKD","LU1282649810.SGD","LU1064131342.USD","LU0348783662.USD","LU0501845795.SGD","LU2399975544.HKD","LU0456827905.SGD","LU0634319403.HKD","BK1147","LU0611395673.USD","IE00B031J352.USD","BK1506","LU0197773160.USD","LU0831093199.SGD","IE00B5MMRT66.SGD","03296","BK1110","LU1366334651.USD","LU0096374516.USD","LU2125910500.SGD","LU1328277881.USD","LU1961090484.USD","LU0329678337.USD","LU2097828714.EUR","HK0000500386.USD","01330","IE00BYV24P56.USD","LU1023057109.AUD","BK1140","LU0164872284.USD","LU0516422952.EUR","LU0327786744.USD","LU1146622755.USD","00553","02691","BK1171","BK1578","LU0871576103.HKD","LU1981816686.USD","LU0456854461.SGD","LU0117841782.USD","00042","LU1366334578.USD","LU1808992512.USD","LU0048580855.USD","LU2279858448.HKD","HK0000252152.HKD","LU1242518931.SGD","LU0607220059.USD","LU1769817096.USD","LU0605514214.HKD","LU0431992006.USD","LU0784639295.USD","LU0140636845.USD","BK1554","LU0886674414.USD","HK0000352291.HKD","LU0328353924.USD","LU0651946864.USD","LU2097828631.EUR","LU0862451753.SGD","LU1720050803.USD","BK1560","LU0315178854.USD","LU1282649141.HKD","LU0181495838.USD","00895","BK1173","03369","LU0348788117.USD","BK1550","LU0049853897.USD","BK1184","SG9999001903.USD","BK1594","LU0266512473.USD","LU1048588211.SGD","IE00B0169L03.USD","LU0348814723.USD","LU0315179316.USD","LU0164865239.USD","LU1515016050.SGD","LU0856984785.SGD","LU0516423091.SGD","00916","BK1214","LU1152091754.HKD","SG9999002828.SGD","LU2543165471.USD","LU1171460220.USD","LU1244550494.USD","LU1044876610.USD","LU1048596156.SGD","LU0106252389.USD","LU0348783233.USD","LU0293314216.USD","LU0061477393.USD","LU0918141705.HKD","LU1224709979.USD","HK0000320223.HKD","LU1820825898.SGD","BK1105","SG9999002463.SGD","IE0003895053.USD","02899","LU1813983027.USD","LU0823426308.USD","LU0708995583.HKD","LU0072913022.USD","LU0878004406.USD","LU0543330566.HKD","LU1226287529.USD","LU1188198961.HKD","LU0620787316.HKD","LU0593848301.USD","LU0762540952.USD","LU0463099449.HKD","LU1655091459.SGD","LU0173614495.USD","LU0197773673.USD","LU1282651121.HKD","HK0000352382.USD","BK1205","LU1880383440.USD","06869","LU0348805143.USD","LU0890818403.SGD","LU0254981946.USD","LU0326950275.SGD","LU0231483743.USD","BK1526","IE0008368742.USD","LU2293587155.HKD","LU2152927971.USD","LU0345780281.USD","LU0828237510.HKD","LU0149721374.USD","LU1719994722.HKD","LU0588545490.SGD","LU0051755006.USD","IE0032431581.USD","BK1552","02218","LU1303224171.USD","LU1251922891.USD","159982","LU1211504680.USD","LU0149534421.HKD","LU0502904849.HKD","LU0196878994.USD","LU0531971595.HKD","HK0000151867.HKD","LU2153591404.USD","LU1988902786.USD","601318","LU2242644610.SGD","LU0348767384.USD","LU0043850808.USD","LU0588545730.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157085512","title":"Movement Alert｜Hengrui Pharma Rises 3.02% in Regular Trading, Pharma Sector Rallies as Multiple Regulatory Milestones Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1157085512","media":"Market Focus","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157085512?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:09","pubTimestamp":1782698980,"startTime":"0","endTime":"0","summary":"On June 29, Hengrui Pharma rose 3.02% in regular trading, trading at HKD 55.55/share, with turnover of HKD 109 million. The stock rebounded from a 6.45% decline in the prior session, supported by a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178163155","title":"AH Share Premium and Deviation Rankings for June 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1178163155","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178163155?lang=en_us&edition=fundamental","pubTime":"2026-06-26 16:24","pubTimestamp":1782462278,"startTime":"0","endTime":"0","summary":"The trading session on June 26 concluded with data revealing the top and bottom three stocks in terms of AH share premium rates and deviation values. The highest AH premium rates were recorded by NE...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512473.USD","LU1008478684.HKD","LU2008162690.USD","IE0008369823.USD","LU0449515922.USD","399300","LU0348788117.USD","01276","LU1831875114.USD","LU0791591158.USD","LU0823426308.USD","BK1562","LU0315179316.USD","LU0708995583.HKD","BK1231","LU0501845795.SGD","LU0871576103.HKD","BK1166","HK0000252152.HKD","LU0096374516.USD","LU1152091754.HKD","LU0417516902.SGD","03328","LU1481107354.HKD","LU0329678170.USD","HK0000306701.USD","LU2476274720.SGD","LU0214875030.USD","LU0531971595.HKD","00042","LU0737861772.HKD","LU0737861699.HKD","LU0039217434.USD","LU2543165471.USD","02691","BK1191","SG9999001226.SGD","02465","BK1205","LU2264538146.SGD","LU0327786744.USD","LU0797268264.HKD","LU0588546209.SGD","HK0001040143.USD","02338","LU1328277881.USD","BK1116","LU0254981946.USD","LU0456846285.SGD","BK1522","LU0348814723.USD","LU0266512127.USD","LU0128522157.USD","LU0540923850.HKD","LU1303224171.USD","LU0228659784.USD","LU2039709279.SGD","LU1961090484.USD","LU0117841782.USD","LU0862451753.SGD","LU1242518931.SGD","BK1240","IE00B543WZ88.USD","LU1688375341.USD","LU0067412154.USD","LU0823426480.USD","SG9999014674.SGD","01812","HK0000320223.HKD","02607","LU0880133367.SGD","01330","01033","LU0348766576.USD","LU1769817096.USD","LU2097828805.USD","IE00BZ08YT58.USD","LU2097828631.EUR","LU1244550221.USD","EWH","LU0173614495.USD","LU0140636845.USD","LU1242518857.USD","BK1144","LU0052750758.USD","LU1282648689.USD","IE0032431581.USD","BK1546","LU3063872942.SGD","BK1507","LU0543330566.HKD","LU0106959298.USD","LU0979878070.USD","LU1807302812.USD","LU2097828557.USD","LU0572944931.SGD","03678","LU1224709979.USD","LU2097828714.EUR","LU0348805143.USD","LU1675838814.USD","LU0061477393.USD","LU0868486357.SGD","BK1183","LU0106252389.USD","LU1152091168.USD","LU1282649141.HKD","IE00BZ08YR35.GBP","LU2045819591.USD","IE00B031HY20.USD","BK1147","BK1523","LU0051755006.USD","LU0165289439.USD","IE00B29SXG58.USD","BK1526","BK1521","LU0417516738.SGD","02218","LU0531970944.HKD","IE00BMCWC346.EUR","BK1610","LU2125910500.SGD","BK1513","LU2778985437.USD","LU0345780521.USD","BK1110","LU0149721374.USD","LU1188198961.HKD","LU1244550494.USD","LU1023057109.AUD","BK1537","LU1880383440.USD","LU0054450605.USD","01349","06869","IE0034224299.USD","LU0828237510.HKD","LU1960683339.HKD","00553","IE0031814852.USD","BK1558","06031","LU0502904849.HKD","LU0348767384.USD","LU1993786604.SGD","LU0228367735.SGD","LU0244354667.USD","LU0329678337.USD","LU1251922891.USD","LU1282649810.SGD","LU0561508036.HKD","IE00BVYPNP33.GBP","LU0516422366.SGD","LU0589944569.HKD","BK1202","BK1506","HK0000352382.USD","LU0607220059.USD","LU0163747925.USD","IE0008368742.USD","SG9999004220.SGD","LU0488056044.USD","LU0469268626.HKD","LU1770034418.SGD","IE00BPRC5H50.USD","LU1794554557.SGD","LU0348825331.USD","LU0348816934.USD","LU1720050803.USD","LU0049853897.USD","LU0516423174.USD","LU0672654166.SGD","IE00BZ08YS42.EUR","BK1154","BK1503","LU1813983027.USD","LU0348735423.USD","LU0048580855.USD","LU2399975544.HKD","LU1048596156.SGD","SG9999001093.SGD","LU1504937902.USD","BK1583","LU0326950275.SGD","00956","LU0823040885.USD","BK1576","LU1105468828.SGD","LU0828237940.HKD","BK1198","SG9999002828.SGD","LU0455707207.USD","IE00B3M56506.USD","HK0000320264.USD","02208","LU1880383366.USD","LU0307460666.USD","159982","LU0463099449.HKD","03296","LU0072913022.USD","03200","BK1171","LU0516423091.SGD","00588","LU0029875118.USD","IE00BYV24P56.USD","BK1592","SG9999011746.SGD","BK1149","BK1163","LU0640798160.USD","LU0918141887.USD","BK1197","LU0516422440.USD","BK1560","LU0620787316.HKD","HK0000252160.HKD","02899","LU0314109678.HKD","HK0000352291.HKD","HK0000500386.USD","BK1105","LU1282649067.USD","BK1140","LU1064131342.USD","LU1769817179.HKD","LU1046422090.SGD","LU0149534421.HKD","IE00BF5LJ272.USD","LU0516422952.EUR","LU1244550577.SGD","LU0456827905.SGD","SG9999002463.SGD","LU2476274308.USD","BK1554","01688","03661","BK1237","BK1141","00187","03986","BK1514","IE00B031J352.USD","IE00BVYPNQ40.USD","LU2226246903.HKD","LU0082770016.SGD","BK1564","BK1544","LU0370786039.SGD","LU0648948544.HKD","LU2242644610.SGD","01108","LU0164939612.USD","HK0000306685.HKD","LU0918141705.HKD","LU0164880469.USD","IE00B5MMRT66.SGD","LU1226287529.USD","LU0348827113.USD","LU0384037296.USD","LU0821914370.USD","03968","LU1366334651.USD","LU0543330483.HKD","LU0359201612.USD","BK1594","LU0211977185.USD","LU0886674414.USD","09989","06066","01081","LU0287142896.SGD","LU0634319403.HKD","03143","LU0456854461.SGD","LU2097828474.EUR","LU1115378108.SGD","LU0359202008.SGD","LU0229945570.USD","LU0043850808.USD","LU2294711473.HKD","LU0320764599.SGD","LU0164865239.USD","LU0791590937.USD","LU0890818403.SGD","LU1211504680.USD","02359","LU0449509016.USD","01057","LU0593848301.USD","LU0320764755.SGD","BK1193","LU1719994722.HKD","IE00BGHQDM52.EUR","LU2177674079.SGD","BK1223","BK1505","00916","LU0431992006.USD","LU0345780281.USD","LU0328353924.USD","LU0359201885.HKD","HK0001040168.HKD","LU0181495838.USD","LU0231483743.USD","03750","SG9999006597.SGD","BK1551","LU1988902786.USD","LU1366334578.USD","LU0082770016.USD","LU1808992512.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646336393","title":"Hengrui Pharma Gets Nod to Trial HRS-4508 Tablets As Advanced Tumor Treatment; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646336393","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646336393?lang=en_us&edition=fundamental","pubTime":"2026-06-26 11:10","pubTimestamp":1782443414,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received approval from China's National Medical Products Administration to conduct clinical trials on HRS-4508 tablets, according to a Shanghai bourse filing on Friday.The drug will be tested as a treatment for advanced solid tumors.The pharmaceutical company invested 81.8 million yuan into the research and development of the drug.The company's Hong Kong shares dropped 4%, while Shanghai shares slipped 1% during the morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","LU0405327148.USD","LU1655091616.SGD","BK0188","LU2543165471.USD","LU1580142542.USD","LU2148510915.USD","LU2097828631.EUR","BK0028","LU2289578879.USD","LU2097828557.USD","LU2097828474.EUR","LU0359201885.HKD","LU2097828805.USD","BK4157","LU2580892789.USD","LU1997245094.SGD","LU2328871848.SGD","LU0359202008.SGD","LU1023057109.AUD","LU1997244956.HKD","BK0012","01276","LU1146622755.USD","LU2495084118.USD","AEIS","BK1191","LU0405327494.USD","BK0060","LU1064131003.USD","LU2488822045.USD","LU1328615791.USD","LU1781817850.SGD","LU1255011170.USD","LU1997245177.USD","LU2580892862.HKD","BK0196","LU1064130708.USD","LU2097828714.EUR","IE00B19Z4B17.USD","IE0031619046.USD","LU1815336091.USD","LU1820825898.SGD","LU1969619763.USD","600276","LU0757428866.USD","IE00B66KJ199.SGD","BK0183","IE00B7SZL793.SGD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646338034","title":"Hengrui Pharmaceuticals Unit Wins China Approval to Expand Indication of Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2646338034","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646338034?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:51","pubTimestamp":1782442263,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  said a unit received China's National Medical Products Administration approval to expand the indication of adebrelimab, according to a Thursday Hong Kong bourse filing.The drug can now be used as neoadjuvant therapy in non-small cell lung cancer. It was previously approved as a first-line treatment of extensive-stage small cell lung cancer.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023057109.AUD","LU2543165471.USD","01276","BK1191","LU0359201612.USD","LU0359201885.HKD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184216560","title":"Movement Alert｜Hengrui Pharmaceuticals Falls 3.53% in Regular Trading, Trading at 54.15 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1184216560","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184216560?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:15","pubTimestamp":1782440114,"startTime":"0","endTime":"0","summary":"On June 26, Hengrui Pharmaceuticals fell 3.53% in regular trading, trading at 54.15 HKD/share, with turnover of 116 million HKD.Within the Pharmaceuticals sector where Hengrui Pharmaceuticals...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646380010","title":"Hengrui Pharmaceuticals Unit Wins China Marketing Approval for Dry Eye Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2646380010","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646380010?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:06","pubTimestamp":1782439585,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  said a unit received marketing approval from China's National Medical Products Administration for Cyclosporine Ophthalmic Solution , marketed as CyclASol, according to a Thursday Hong Kong bourse filing.CyclASol is indicated to promote tear secretion and improve the signs and symptoms of dry eye disease in patients with reduced tear production.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01276","LU0359201885.HKD","BK1191","LU0359202008.SGD","LU2543165471.USD","LU0359201612.USD","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141236799","title":"Hengrui Pharma Secures NMPA Approval for Adebrelimab as China’s First Domestic Peri-operative PD-L1 Therapy for Resectable NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1141236799","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141236799?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:04","pubTimestamp":1782392687,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, 01276.HK) announced that its wholly owned subsidiary, Shanghai Suncadia Medicine Co., Ltd., has received National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116136614","title":"Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop","url":"https://stock-news.laohu8.com/highlight/detail?id=1116136614","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116136614?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:04","pubTimestamp":1782392677,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) announced that its subsidiary Chengdu Suncadia Medicine has received National Medical Products Administration (NMPA) approval to launch...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}